Loading…

More significance of TB‐IGRA except for the diagnose of tuberculosis

Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical laboratory analysis 2018-01, Vol.32 (1), p.n/a
Main Authors: Xu, Jun‐Chi, Li, Ze‐Yi, Chen, Xin‐Nian, Shi, Cui‐Lin, Wu, Mei‐Ying, Chen, Hui, Zhu, Xiao‐Yan, Song, Hua‐Feng, Wu, Min‐Juan, Xu, Ping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813
cites cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813
container_end_page n/a
container_issue 1
container_start_page
container_title Journal of clinical laboratory analysis
container_volume 32
creator Xu, Jun‐Chi
Li, Ze‐Yi
Chen, Xin‐Nian
Shi, Cui‐Lin
Wu, Mei‐Ying
Chen, Hui
Zhu, Xiao‐Yan
Song, Hua‐Feng
Wu, Min‐Juan
Xu, Ping
description Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study. Design A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis. Results TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA. Conclusions IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.
doi_str_mv 10.1002/jcla.22183
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6817251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1870645028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</originalsourceid><addsrcrecordid>eNp9kU1rFEEQhhtRzBq9-ANkwIsIk1T1fFVfhM1iPmRFkHhuenpqNr3MTq_dM2pu_gR_o78ks9kYogdPdXifeqjiFeIlwhECyOO17cyRlEjZIzFDUJRKksVjMQOiKiXA7EA8i3ENAKSwfCoOplyCqtRMnH70gZPoVr1rnTW95cS3yeXJ75-_Ls4-zxP-YXk7JK0PyXDFSePMqvfxFhrGmoMdOx9dfC6etKaL_OJuHoovp-8vF-fp8tPZxWK-TG2eU5ZWxiLbghXVec2mLPMS81oWuW0Zcq4LhdK0BpUtGtMQkZw2VGbIUN0AYXYo3u2927HecGO5H4Lp9Da4jQnX2hun_056d6VX_psuCStZ7ARv7gTBfx05DnrjouWuMz37MWqkCsq8AEkT-vofdO3H0E_vaVSkihIA5US93VM2-BgDt_fHIOhdPXpXj76tZ4JfPTz_Hv3TxwTgHvjuOr7-j0p_WCzne-kN2iibWw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989560012</pqid></control><display><type>article</type><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><source>NCBI_PubMed Central(免费)</source><creator>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</creator><creatorcontrib>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</creatorcontrib><description>Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study. Design A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis. Results TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA. Conclusions IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</description><identifier>ISSN: 0887-8013</identifier><identifier>ISSN: 1098-2825</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.22183</identifier><identifier>PMID: 28220979</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; CD28 antigen ; CD4 antigen ; CD4-Positive T-Lymphocytes - immunology ; CD8 antigen ; Female ; Humans ; Immunoassay ; Interferon ; Interferon-gamma - analysis ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Interferon-gamma Release Tests - statistics &amp; numerical data ; Leukocytes, Mononuclear - immunology ; Lungs ; Lymphocytes ; Lymphocytes T ; Male ; Medical diagnosis ; Middle Aged ; Mycobacterium tuberculosis ; Prognosis ; Pulmonary lesions ; Retrospective Studies ; TB‐IGRA ; Tuberculosis ; Tuberculosis - diagnosis ; Tuberculosis - epidemiology ; Tuberculosis - immunology ; γ‐interferon</subject><ispartof>Journal of clinical laboratory analysis, 2018-01, Vol.32 (1), p.n/a</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><rights>Copyright © 2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</citedby><cites>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</cites><orcidid>0000-0002-1447-7593</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817251/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817251/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28220979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Jun‐Chi</creatorcontrib><creatorcontrib>Li, Ze‐Yi</creatorcontrib><creatorcontrib>Chen, Xin‐Nian</creatorcontrib><creatorcontrib>Shi, Cui‐Lin</creatorcontrib><creatorcontrib>Wu, Mei‐Ying</creatorcontrib><creatorcontrib>Chen, Hui</creatorcontrib><creatorcontrib>Zhu, Xiao‐Yan</creatorcontrib><creatorcontrib>Song, Hua‐Feng</creatorcontrib><creatorcontrib>Wu, Min‐Juan</creatorcontrib><creatorcontrib>Xu, Ping</creatorcontrib><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><title>Journal of clinical laboratory analysis</title><addtitle>J Clin Lab Anal</addtitle><description>Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study. Design A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis. Results TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA. Conclusions IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</description><subject>Adult</subject><subject>CD28 antigen</subject><subject>CD4 antigen</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8 antigen</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Interferon</subject><subject>Interferon-gamma - analysis</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interferon-gamma Release Tests - statistics &amp; numerical data</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Lungs</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Middle Aged</subject><subject>Mycobacterium tuberculosis</subject><subject>Prognosis</subject><subject>Pulmonary lesions</subject><subject>Retrospective Studies</subject><subject>TB‐IGRA</subject><subject>Tuberculosis</subject><subject>Tuberculosis - diagnosis</subject><subject>Tuberculosis - epidemiology</subject><subject>Tuberculosis - immunology</subject><subject>γ‐interferon</subject><issn>0887-8013</issn><issn>1098-2825</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFEEQhhtRzBq9-ANkwIsIk1T1fFVfhM1iPmRFkHhuenpqNr3MTq_dM2pu_gR_o78ks9kYogdPdXifeqjiFeIlwhECyOO17cyRlEjZIzFDUJRKksVjMQOiKiXA7EA8i3ENAKSwfCoOplyCqtRMnH70gZPoVr1rnTW95cS3yeXJ75-_Ls4-zxP-YXk7JK0PyXDFSePMqvfxFhrGmoMdOx9dfC6etKaL_OJuHoovp-8vF-fp8tPZxWK-TG2eU5ZWxiLbghXVec2mLPMS81oWuW0Zcq4LhdK0BpUtGtMQkZw2VGbIUN0AYXYo3u2927HecGO5H4Lp9Da4jQnX2hun_056d6VX_psuCStZ7ARv7gTBfx05DnrjouWuMz37MWqkCsq8AEkT-vofdO3H0E_vaVSkihIA5US93VM2-BgDt_fHIOhdPXpXj76tZ4JfPTz_Hv3TxwTgHvjuOr7-j0p_WCzne-kN2iibWw</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Xu, Jun‐Chi</creator><creator>Li, Ze‐Yi</creator><creator>Chen, Xin‐Nian</creator><creator>Shi, Cui‐Lin</creator><creator>Wu, Mei‐Ying</creator><creator>Chen, Hui</creator><creator>Zhu, Xiao‐Yan</creator><creator>Song, Hua‐Feng</creator><creator>Wu, Min‐Juan</creator><creator>Xu, Ping</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1447-7593</orcidid></search><sort><creationdate>201801</creationdate><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><author>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>CD28 antigen</topic><topic>CD4 antigen</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8 antigen</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Interferon</topic><topic>Interferon-gamma - analysis</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interferon-gamma Release Tests - statistics &amp; numerical data</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Lungs</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Middle Aged</topic><topic>Mycobacterium tuberculosis</topic><topic>Prognosis</topic><topic>Pulmonary lesions</topic><topic>Retrospective Studies</topic><topic>TB‐IGRA</topic><topic>Tuberculosis</topic><topic>Tuberculosis - diagnosis</topic><topic>Tuberculosis - epidemiology</topic><topic>Tuberculosis - immunology</topic><topic>γ‐interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Jun‐Chi</creatorcontrib><creatorcontrib>Li, Ze‐Yi</creatorcontrib><creatorcontrib>Chen, Xin‐Nian</creatorcontrib><creatorcontrib>Shi, Cui‐Lin</creatorcontrib><creatorcontrib>Wu, Mei‐Ying</creatorcontrib><creatorcontrib>Chen, Hui</creatorcontrib><creatorcontrib>Zhu, Xiao‐Yan</creatorcontrib><creatorcontrib>Song, Hua‐Feng</creatorcontrib><creatorcontrib>Wu, Min‐Juan</creatorcontrib><creatorcontrib>Xu, Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Jun‐Chi</au><au>Li, Ze‐Yi</au><au>Chen, Xin‐Nian</au><au>Shi, Cui‐Lin</au><au>Wu, Mei‐Ying</au><au>Chen, Hui</au><au>Zhu, Xiao‐Yan</au><au>Song, Hua‐Feng</au><au>Wu, Min‐Juan</au><au>Xu, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>More significance of TB‐IGRA except for the diagnose of tuberculosis</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J Clin Lab Anal</addtitle><date>2018-01</date><risdate>2018</risdate><volume>32</volume><issue>1</issue><epage>n/a</epage><issn>0887-8013</issn><issn>1098-2825</issn><eissn>1098-2825</eissn><abstract>Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study. Design A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis. Results TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA. Conclusions IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>28220979</pmid><doi>10.1002/jcla.22183</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1447-7593</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-8013
ispartof Journal of clinical laboratory analysis, 2018-01, Vol.32 (1), p.n/a
issn 0887-8013
1098-2825
1098-2825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6817251
source NCBI_PubMed Central(免费)
subjects Adult
CD28 antigen
CD4 antigen
CD4-Positive T-Lymphocytes - immunology
CD8 antigen
Female
Humans
Immunoassay
Interferon
Interferon-gamma - analysis
Interferon-gamma - immunology
Interferon-gamma - metabolism
Interferon-gamma Release Tests - statistics & numerical data
Leukocytes, Mononuclear - immunology
Lungs
Lymphocytes
Lymphocytes T
Male
Medical diagnosis
Middle Aged
Mycobacterium tuberculosis
Prognosis
Pulmonary lesions
Retrospective Studies
TB‐IGRA
Tuberculosis
Tuberculosis - diagnosis
Tuberculosis - epidemiology
Tuberculosis - immunology
γ‐interferon
title More significance of TB‐IGRA except for the diagnose of tuberculosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=More%20significance%20of%20TB%E2%80%90IGRA%20except%20for%20the%20diagnose%20of%20tuberculosis&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Xu,%20Jun%E2%80%90Chi&rft.date=2018-01&rft.volume=32&rft.issue=1&rft.epage=n/a&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.22183&rft_dat=%3Cproquest_pubme%3E1870645028%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1989560012&rft_id=info:pmid/28220979&rfr_iscdi=true